Form 4: SelectQuote Executive Sarah Taylor Anderson Reports Stock Unit Grants
SEC Form 4 Filing
Sarah Taylor Anderson, an officer at SelectQuote, Inc., reported the acquisition of restricted stock units and price-vested restricted stock units on October 28, 2024.
Summary
- On October 28, 2024, Sarah Taylor Anderson, an officer of SelectQuote, Inc., reported the acquisition of 43,685 restricted stock units (RSUs) and 43,685 price-vested units (PVUs).
- The RSUs and PVUs were granted under the company's 2020 Omnibus Incentive Plan.
- The RSUs vest ratably in three annual installments starting August 1, 2025, contingent upon continued employment.
- The PVUs are eligible to vest in three ratable annual installments commencing on August 1, 2025, subject to continued employment and the company's common stock reaching certain predetermined average trading prices during the five-year performance period.
- One-third of the PVUs will vest if the 60-day average closing price of SelectQuote's common stock exceeds $3.13, $6.00, and $9.00.
Sentiment
Score: 7
Explanation: The document is neutral to positive. It reflects standard executive compensation practices, aligning management with shareholder interests through stock-based incentives.
Positives
- The grant of RSUs and PVUs aligns the executive's interests with the company's long-term performance.
- The vesting conditions based on stock price targets in the PVUs incentivize efforts to increase shareholder value.
Risks
- The vesting of RSUs and PVUs is contingent on continued employment, creating a potential risk of forfeiture if the executive leaves the company before the vesting dates.
- The PVUs may not vest if the stock price targets are not met within the five-year performance period.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance, but the vesting of PVUs is tied to future stock price performance.
Industry Context
Stock grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders. The specific vesting conditions, such as price targets, can vary depending on the company's goals and industry practices.
Comparison to Industry Standards
- Stock-based compensation is a standard practice across the industry, with companies like eHealth and GoHealth also utilizing similar incentive plans.
- The vesting schedules and performance metrics (like stock price targets) are tailored to SelectQuote's specific circumstances and strategic goals, but the general structure is consistent with industry norms.
- Comparing the size of the grant to similar roles at comparable companies would require additional data on executive compensation packages within the insurance technology sector.
Stakeholder Impact
- Shareholders may view the stock grants positively as they align management's interests with the company's performance.
- Employees may be motivated by the potential for similar stock-based compensation opportunities.
Key Dates
| Date | Description |
|---|---|
| 10/28/2024 | Date of transaction: Grant of restricted stock units and price-vested units |
| 08/01/2025 | Commencement date for ratable vesting of restricted stock units and price-vested units |
| 10/28/2034 | Expiration date for restricted stock units and price-vested units |
| 10/30/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.